Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$0.53 - $0.93 $39,802 - $69,842
-75,099 Reduced 12.56%
523,017 $303,000
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $92,385 - $167,174
-146,644 Reduced 19.69%
598,116 $496,000
Q3 2023

Nov 14, 2023

BUY
$1.12 - $1.88 $295,291 - $495,667
263,653 Added 54.8%
744,760 $841,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $2.04 $732,593 - $1.14 Million
-559,232 Reduced 53.75%
481,107 $769,000
Q1 2023

May 16, 2023

BUY
$1.45 - $2.95 $955,912 - $1.94 Million
659,250 Added 172.99%
1,040,339 $1.58 Million
Q4 2022

Feb 14, 2023

SELL
$2.02 - $3.25 $924,794 - $1.49 Million
-457,819 Reduced 54.57%
381,089 $914,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $436,382 - $699,102
222,644 Added 36.13%
838,908 $1.72 Million
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $716,107 - $1.45 Million
-550,852 Reduced 47.2%
616,264 $1.2 Million
Q1 2022

May 16, 2022

SELL
$2.35 - $3.47 $2.32 Million - $3.42 Million
-985,873 Reduced 45.79%
1,167,116 $2.87 Million
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $812,221 - $1.6 Million
278,158 Added 14.84%
2,152,989 $6.93 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $5.21 Million - $6.94 Million
1,046,640 Added 126.38%
1,874,831 $9.84 Million
Q2 2021

Aug 11, 2021

BUY
$2.56 - $5.49 $1.04 Million - $2.23 Million
406,238 Added 96.28%
828,191 $4.55 Million
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $336,801 - $657,326
125,205 Added 42.19%
421,953 $1.15 Million
Q4 2020

Feb 16, 2021

BUY
$3.17 - $4.49 $277,802 - $393,481
87,635 Added 41.91%
296,748 $944,000
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $508,641 - $887,562
170,685 Added 444.17%
209,113 $836,000
Q2 2020

Aug 14, 2020

SELL
$2.29 - $4.24 $113,508 - $210,164
-49,567 Reduced 56.33%
38,428 $151,000
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $57,672 - $131,866
30,038 Added 51.83%
87,995 $216,000
Q3 2019

Nov 14, 2019

SELL
$2.17 - $3.14 $63,394 - $91,731
-29,214 Reduced 33.51%
57,957 $150,000
Q2 2019

Aug 16, 2019

BUY
$2.53 - $3.04 $39,574 - $47,551
15,642 Added 21.87%
87,171 $261,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $130,616 - $156,946
51,627 Added 259.41%
71,529 $214,000
Q1 2019

May 15, 2019

SELL
$2.51 - $3.73 $203,626 - $302,599
-81,126 Reduced 80.3%
19,902 $59,000
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $111,724 - $186,910
70,267 Added 228.43%
101,028 $240,000
Q3 2018

Nov 14, 2018

BUY
$1.59 - $2.42 $5,717 - $8,702
3,596 Added 13.24%
30,761 $66,000
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.78 $88,557 - $129,848
27,165
27,165 $89,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.